MBRX - Moleculin Biotech

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Moleculin Biotech GAAP EPS of -$0.28 in-line
• Moleculin Biotech reports FY results
• Moleculin drops as 2022 net loss widens
• Moleculin Biotech reports FY results
• Moleculin drug shows promise in interim data from phase 1 trial in blood cancer
• FDA grants fast track designation to Moleculin Biotech's treatment for brain cancer
• Moleculin Biotech GAAP EPS of -$0.30
• Moleculin Biotech rises 7% as WP1096 compound selected for NIAID-funded animal studies
• Moleculin brain cancer therapy WP1122 gets FDA orphan drug status
• Moleculin Biotech GAAP EPS of -$0.24
• Moleculin potential COVID drug WP1122 shows safety in preliminary data from phase 1a trial
• Moleculin begins human trial of WP1122 to treat COVID-19
• Moleculin Biotech GAAP EPS of -$0.24 misses by $0.01
• Moleculin cleared to conduct phase 1 study of WP1066 for treatment of recurrent brain tumor
• Moleculin Biotech GAAP EPS of -$0.59 beats by $0.12
• Moleculin gains 5% on FDA green light for Phase 1 study of WP1122 in glioblastoma multiforme
• Moleculin Biotech EPS beats by $0.05
• MHRA OKs phase 1 trial of Moleculin Biotech's COVID-19 treatment
• Moleculin says no dose-limiting toxicity in early-stage study for lung cancer therapy
• Moleculin Biotech EPS beats by $0.05

Date		Price		Open	High	Low		Vol	Change
Dec 4		0.59		0.61	0.61	0.58		58.5K	-3.28%
Dec 1		0.61		0.6	0.61	0.58		54.8K	1.67%
Nov 30		0.6		0.56	0.61	0.56		76.4K	5.26%
Nov 29		0.57		0.6	0.6	0.55		62.4K	-1.72%
Nov 28		0.58		0.57	0.6	0.56		73.8K	5.45%
Nov 27		0.55		0.57	0.6	0.54		129K	-1.79%
Nov 24		0.56		0.54	0.59	0.54		28.7K	1.82%
Nov 22		0.55		0.52	0.57	0.52		85.2K	5.77%
Nov 21		0.52		0.54	0.57	0.52		43.9K	-3.7%
Nov 20		0.54		0.57	0.61	0.54		140K	-8.47%
Nov 17		0.59		0.6	0.63	0.54		187K	-3.28%
Nov 16		0.61		0.57	0.62	0.56		110K	7.02%
Nov 15		0.57		0.54	0.59	0.53		124K	3.64%
Nov 14		0.55		0.55	0.59	0.53		136K	-5.17%
Nov 13		0.58		0.6	0.65	0.55		1.5M	7.41%
Nov 10		0.54		0.51	0.55	0.5		69.2K	0%
Nov 9		0.54		0.54	0.55	0.49		63.2K	-3.57%
Nov 8		0.56		0.58	0.59	0.53		20.4K	0%
Nov 7		0.56		0.57	0.6	0.56		69.3K	-5.08%
Nov 6		0.59		0.51	0.6	0.51		143K	15.69%
Nov 3		0.51		0.52	0.54	0.48		51.3K	0%
Nov 2		0.51		0.51	0.53	0.47		24.9K	6.25%
Nov 1		0.48		0.46	0.5	0.46		39.3K	0%
Oct 31		0.48		0.47	0.51	0.45		125K	6.67%
Oct 30		0.45		0.47	0.51	0.45		153K	-6.25%
Oct 27		0.48		0.47	0.51	0.47		113K	-2.04%
Oct 26		0.49		0.49	0.51	0.46		70.5K	4.26%
Oct 25		0.47		0.51	0.55	0.46		78.2K	-4.08%
Oct 24		0.49		0.48	0.52	0.48		126K	-5.77%
Oct 23		0.52		0.58	0.61	0.51		123K	-11.86%
Oct 20		0.59		0.63	0.63	0.56		126K	-4.84%
Oct 19		0.62		0.6	0.67	0.6		132K	6.90%
Oct 18		0.58		0.7	0.7	0.55		326K	-4.92%
Oct 17		0.61		0.52	0.74	0.52		2.0M	24.49%
Oct 16		0.49		0.46	0.53	0.46		239K	8.89%
Oct 13		0.45		0.4	0.46	0.4		107K	9.76%
Oct 12		0.41		0.45	0.48	0.4		103K	-8.89%
Oct 11		0.45		0.42	0.48	0.42		19.9K	4.65%
Oct 10		0.43		0.43	0.5	0.43		66.2K	-6.52%
Oct 9		0.46		0.54	0.54	0.45		71.8K	-8%
Oct 6		0.5		0.53	0.53	0.49		80.9K	2.04%
Oct 5		0.49		0.45	0.52	0.44		183K	13.95%
Oct 4		0.43		0.41	0.45	0.41		68.1K	4.88%
Oct 3		0.41		0.42	0.44	0.41		19.3K	-6.82%
Oct 2		0.44		0.44	0.44	0.41		58.5K	2.33%
Sep 29		0.43		0.43	0.44	0.41		52.1K	2.38%
Sep 28		0.42		0.43	0.44	0.42		52.0K	5%
Sep 27		0.4		0.44	0.44	0.4		47.0K	-4.76%
Sep 26		0.42		0.42	0.44	0.41		67.6K	2.44%
Sep 25		0.41		0.4	0.44	0.38		157K	5.13%
Sep 22		0.39		0.43	0.43	0.38		62.1K	-7.14%
Sep 21		0.42		0.38	0.42	0.38		126K	10.53%
Sep 20		0.38		0.4	0.4	0.38		25.7K	-5%
Sep 19		0.4		0.37	0.4	0.37		46.9K	5.26%
Sep 18		0.38		0.4	0.4	0.37		275K	-5%
Sep 15		0.4		0.38	0.42	0.38		114K	2.56%
Sep 14		0.39		0.4	0.4	0.37		141K	-2.5%
Sep 13		0.4		0.41	0.43	0.4		45.0K	-2.44%
Sep 12		0.41		0.44	0.45	0.4		70.1K	2.50%
Sep 11		0.4		0.44	0.44	0.38		56.3K	0%